• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化候选药物中枢神经系统暴露的方法。

Methods to optimize CNS exposure of drug candidates.

机构信息

Worldwide Medicinal Chemistry, Pfizer Worldwide Research & Development, 610 Main Street, Cambridge, MA 02139, United States.

出版信息

Bioorg Med Chem Lett. 2020 Dec 1;30(23):127503. doi: 10.1016/j.bmcl.2020.127503. Epub 2020 Aug 25.

DOI:10.1016/j.bmcl.2020.127503
PMID:32853684
Abstract

Among the most devastating disorders of our time, neurologic and psychiatric diseases combine to cause more disability than any other disease area. One of the key objectives within the medicinal chemistry discipline is to design molecules that penetrate into the target tissue. The objective of tissue specificity can be to gain or restrict drug access to the compartment of interest. This article briefly reviews the progress of CNS drug discovery over the past few decades. Included are the most recent efforts to harness structural and physicochemical properties assessment coupled with the impact of efflux transporters in determining brain penetration and the translation from rodent to human brain tissue targeting.

摘要

在我们这个时代最具破坏性的疾病中,神经和精神疾病相结合导致的残疾比任何其他疾病领域都多。药物化学学科的主要目标之一是设计能够穿透靶组织的分子。组织特异性的目标可以是增加或限制药物进入感兴趣的隔室的机会。本文简要回顾了过去几十年中枢神经系统药物发现的进展。其中包括利用结构和物理化学性质评估以及外排转运体的影响来确定脑穿透性,并将啮齿动物脑组织靶向转化为人体的最新努力。

相似文献

1
Methods to optimize CNS exposure of drug candidates.优化候选药物中枢神经系统暴露的方法。
Bioorg Med Chem Lett. 2020 Dec 1;30(23):127503. doi: 10.1016/j.bmcl.2020.127503. Epub 2020 Aug 25.
2
Harnessing Preclinical Data as a Predictive Tool for Human Brain Tissue Targeting.利用临床前数据作为预测人类脑组织靶向的工具。
ACS Chem Neurosci. 2021 Mar 17;12(6):1007-1017. doi: 10.1021/acschemneuro.0c00807. Epub 2021 Mar 2.
3
Experimental and Computational Methods to Assess Central Nervous System Penetration of Small Molecules.评估小分子进入中枢神经系统的实验和计算方法。
Molecules. 2024 Mar 13;29(6):1264. doi: 10.3390/molecules29061264.
4
In vitro P-glycoprotein efflux ratio can predict the in vivo brain penetration regardless of biopharmaceutics drug disposition classification system class.无论生物药剂学药物处置分类系统类别如何,体外 P-糖蛋白外排比值均可预测体内脑穿透。
Drug Metab Dispos. 2013 Dec;41(12):2012-7. doi: 10.1124/dmd.113.053868. Epub 2013 Sep 5.
5
Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.整合计算机模拟和体外实验方法以预测药物进入中枢神经系统的可及性
Mol Pharm. 2016 May 2;13(5):1540-50. doi: 10.1021/acs.molpharmaceut.6b00031. Epub 2016 Apr 4.
6
Application of a high-resolution in vitro human MDR1-MDCK assay and in vivo studies in preclinical species to improve prediction of CNS drug penetration.应用高分辨率体外人 MDR1-MDCK 测定法和临床前物种的体内研究来改善对 CNS 药物渗透的预测。
Pharmacol Res Perspect. 2022 Feb;10(1):e00932. doi: 10.1002/prp2.932.
7
Molecular properties determining unbound intracellular and extracellular brain exposure of CNS drug candidates.决定中枢神经系统候选药物细胞内和细胞外未结合脑暴露的分子特性。
Mol Pharm. 2015 Feb 2;12(2):520-32. doi: 10.1021/mp5005965. Epub 2014 Dec 26.
8
Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.血脑屏障模型:中枢神经系统靶向生物治疗药物临床前开发中从体外到体内的转化
Expert Opin Drug Discov. 2015 Feb;10(2):141-55. doi: 10.1517/17460441.2015.974545. Epub 2014 Nov 12.
9
A combo-strategy to improve brain delivery of antiepileptic drugs: Focus on BCRP and intranasal administration.联合策略提高抗癫痫药物脑内递送:关注 BCRP 和鼻内给药。
Int J Pharm. 2021 Jan 25;593:120161. doi: 10.1016/j.ijpharm.2020.120161. Epub 2020 Dec 9.
10
Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.犬 P-糖蛋白缺陷型 MDCK II 细胞系的特征鉴定和验证及其在外排底物筛选中的应用。
Pharm Res. 2020 Sep 11;37(10):194. doi: 10.1007/s11095-020-02895-9.

引用本文的文献

1
Engineering Exosomes for CNS Disorders: Advances, Challenges, and Therapeutic Potential.用于中枢神经系统疾病的工程化外泌体:进展、挑战与治疗潜力
Int J Mol Sci. 2025 Mar 28;26(7):3137. doi: 10.3390/ijms26073137.
2
Log BB Prediction Models Using TLC and HPLC Retention Values as Protein Affinity Data.使用TLC和HPLC保留值作为蛋白质亲和力数据的Log BB预测模型。
Pharmaceutics. 2024 Nov 30;16(12):1534. doi: 10.3390/pharmaceutics16121534.
3
Applicability of MDR1 Overexpressing Abcb1KO-MDCKII Cell Lines for Investigating In Vitro Species Differences and Brain Penetration Prediction.
过表达MDR1的Abcb1基因敲除MDCKII细胞系在研究体外种属差异和脑穿透预测中的适用性
Pharmaceutics. 2024 May 29;16(6):736. doi: 10.3390/pharmaceutics16060736.
4
Why 90% of clinical drug development fails and how to improve it?为什么90%的临床药物研发会失败以及如何改进?
Acta Pharm Sin B. 2022 Jul;12(7):3049-3062. doi: 10.1016/j.apsb.2022.02.002. Epub 2022 Feb 11.
5
Blood-brain barrier penetration prediction enhanced by uncertainty estimation.通过不确定性估计增强血脑屏障穿透预测
J Cheminform. 2022 Jul 7;14(1):44. doi: 10.1186/s13321-022-00619-2.
6
Structure‒tissue exposure/selectivity relationship (STR) correlates with clinical efficacy/safety.结构-组织暴露/选择性关系(STR)与临床疗效/安全性相关。
Acta Pharm Sin B. 2022 May;12(5):2462-2478. doi: 10.1016/j.apsb.2022.02.015. Epub 2022 Feb 23.
7
1-Hydroxy-2(1)-pyridinone-Based Chelators with Potential Catechol -Methyl Transferase Inhibition and Neurorescue Dual Action against Parkinson's Disease.基于 1-羟基-2(1)-吡啶酮的螯合剂,具有潜在的儿茶酚-O-甲基转移酶抑制和神经保护双重作用,可治疗帕金森病。
Molecules. 2022 Apr 28;27(9):2816. doi: 10.3390/molecules27092816.